| SYF |
Report |
2Q26 diluted EPS |
BEAT |
pred ~$2.18 vs. cons $2.09 |
MEDIUM |
| SYF |
Report |
2Q26 period-end loan receivables |
IN-LINE |
pred ~$102.6B vs. cons $102.11B |
HIGH |
| SYF |
Report |
2Q26 net charge-off rate |
BEAT |
pred ~5.50% vs. cons 5.60% |
HIGH |
| SYF |
Guide |
FY2026 diluted EPS |
UNCHANGED |
guide ~$9.30 midpoint vs. cons $9.35 (FY2026) |
HIGH |
| SYF |
Guide |
Year-end loan receivables growth |
BETTER |
guide ~5.0% vs. cons 4.5% (FY2026 year-end) |
MEDIUM |
| SYF |
Guide |
Net charge-off rate |
BETTER |
guide ~5.30% vs. cons 5.35% (FY2026) |
MEDIUM |
| SYF |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.4% |
— |
MEDIUM |
| SYF |
Return |
5-day cumulative residual |
+0.8% (FADE) |
The predicted Q2 EPS beat of ~$2.18 vs. $2.09 consensus should drive the initial gain, but an unchanged FY2026 midpoint of ~$9.30 vs. $9.35 consensus leaves only ~$4.85 for 2H26 versus ~$4.99 implied by pre-report estimates, prompting out-period estimate cuts and a partial fade. |
MEDIUM |